The role of MHC class II molecules in susceptibility to type I diabetes: Identification of peptide epitopes and characterization of the T cell repertoire (vol 96, pg 9299, 1999)

被引：0
|
作者：
Chao, CC
Sytwu, HK
Chen, ELC
Toma, J
McDevitt, HO
机构：
来源：
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 1999年 / 96卷 / 22期
关键词：
D O I：
暂无
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：12970 / 12970
页数：1
相关论文
共 39 条
  • [21] MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice
    Serreze, DV
    Holl, TM
    Marron, MP
    Graser, RT
    Johnson, EA
    Choisy-Rossi, C
    Slattery, RM
    Lieberman, SM
    DiLorenzo, TP
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (02): : 871 - 879
  • [22] Gp96 can chaperone both MHC class I and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T-cell effector function
    Doody, ADH
    Kovalchin, JT
    Mihalyo, MA
    Hagymasi, AT
    Drake, CG
    Adler, AJ
    [J]. IMMUNOLOGY, 2005, 114 (01) : 141 - 141
  • [23] The majority of immunogenic Epitopes generate CD4+ T cells that are dependent on MHC class II-bound peptide-flanking residues (vol 169, pg 739, 2002)
    Arnold, PY
    La Gruta, NL
    Miller, T
    Vignali, KM
    Adams, PS
    Woodland, DL
    Vignali, DAA
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (08): : 4674 - 4674
  • [24] Murine T lymphocytes incapable of producing macrophage inhibitory protein-1α are impaired in causing GVHD across a class I but not class II MHC barrier (vol 93, pg 43, 1999)
    Serody
    [J]. BLOOD, 1999, 94 (04) : 1494 - 1494
  • [25] Identification of cytotoxic T cells and their T cell receptor sequences targeting COVID-19 using MHC class I-binding peptides (vol 2, pg 1, 2022)
    Hikichi, Tetsuro
    Sakamoto, Michiko
    Harada, Makiko
    Saito, Maki
    Yamane, Yuka
    Tokumura, Kimihisa
    Nakamura, Yusuke
    [J]. JOURNAL OF HUMAN GENETICS, 2022, 67 (07) : 445 - 446
  • [26] In Silico Screening of Prospective MHC Class I and II Restricted T-Cell Based Epitopes of the Spike Protein of SARS-CoV-2 for Designing of a Peptide Vaccine for COVID-19
    Sarma, Kishore
    Bali, Nargis K.
    Sarmah, Neelanjana
    Borkakoty, Biswajyoti
    [J]. COVID, 2022, 2 (12): : 1731 - 1747
  • [27] The alloreactive and self-restricted CD4+ T cell response directed against a single MHC class II/peptide combination (vol 165, pg 1285, 2000)
    Kovalik, JP
    Singh, N
    Mendiratta, SK
    Martin, WD
    Ignatowicz, L
    Van Kaer, L
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (07): : 4141 - 4141
  • [28] HLA class I epitope discovery in type 1 diabetes - Independent and reproducible identification of proinsulin epitopes of CD8 T cells - Report of the IDS T Cell Workshop Committee
    Pinkse, Gabrielle G. M.
    Boitard, Christian
    Tree, Timothy I. M.
    Peakman, Mark
    Roep, Bart O.
    [J]. IMMUNOLOGY OF DIABETES IV: PROGRESS IN OUR UNDERSTANDING, 2006, 1079 : 19 - 23
  • [29] Identification of Salmonella typhimurium genes responsible for interference with peptide presentation on MHC class I molecules:: Δyej Salmonella mutants induce superior CD8+ T-cell responses
    Qimron, U
    Madar, N
    Mittrücker, HW
    Zilka, A
    Yosef, I
    Bloushtain, N
    Kaufmann, SHE
    Rosenshine, I
    Apte, RN
    Porgador, A
    [J]. CELLULAR MICROBIOLOGY, 2004, 6 (11) : 1057 - 1070
  • [30] T cell recognition of hypervariable region-1 from hepatitis C virus envelope protein with multiple class II MHC molecules in mice and humans: Preferential help for induction of antibodies to the hypervariable region (vol 162, pg 568, 1999)
    Shirai, M
    Arichi, T
    Chen, M
    Nishioka, M
    Ikeda, K
    Takahashi, H
    Enomoto, N
    Saito, T
    Major, ME
    Nakazawa, T
    Akatsuka, T
    Feinstone, SM
    Berzofsky, JA
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (12): : 7207 - 7207
1234